Dapagliflozin going off-patent- NPPA brings Dapagliflozin, Metformin Combination under price control Farhat Nasim14 Jan 2021 5:15 PM ISTNew Delhi: With the popular antidiabetic drug, Dapagliflozin going off-patent, the apex drug price regulator, National Pharmaceutical Pricing...
SEBI imposes Rs 1 lakh fine on Fortis Healthcare Holdings for disclosure lapses Ruchika Sharma13 Jan 2021 3:07 PM ISTSebi found that Fortis Healthcare Holdings had failed to make timely disclosures about the change in shareholding in the prescribed format and has...
NPPA sets ceiling prices of 14 formulations including Diabetes FDCs, details Ruchika Sharma12 Jan 2021 6:40 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority, the pharma price regulator has fixed the price of 14...
Indian Govt wants Serum Institute of India to bring down AstraZeneca covid vaccine price: Sources Ruchika Sharma11 Jan 2021 4:25 PM ISTSenior officials have been discussing the terms of the deal with the Serum Institute for weeks, hoping to bring down prices below $3 per shot, one of...
Death of Covaxin volunteer due to cardiorespiratory failure and not related to vaccine trial, placebo: Bharat Biotech MD Bureau10 Jan 2021 11:00 AM IST"As per the post mortem report issued by the Gandhi Medical College, Bhopal, that the site received from the Bhopal Police, the probable cause of...
NPPA fixes retail price of 7 formulations, Details Ruchika Sharma9 Jan 2021 3:24 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...
Bharat Biotech to begin Phase 1 trials of intranasal vaccine for COVID-19 Ruchika Sharma8 Jan 2021 2:31 PM ISTAn intranasal vaccine will not only be simple to administer but reduce the use of medical consumables such as needles, syringes, etc., significantly...
Cadila Healthcare gets CDSCO panel go-ahead for Phase 3 trial of Novel Corona Virus 2019-nCoV Vaccine MD Bureau7 Jan 2021 5:28 PM ISTNew Delhi: Pharmaceutical major, Cadila Healthcare has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Wockhardt secures CDSCO panel conditional nod to conduct Phase IV Trial of Levonadifloxacin MD Bureau6 Jan 2021 6:18 PM ISTNew Delhi: Pharmaceutical and biotechnology major Wockhardt Ltd. has recently secured permission from the Subject Expert Committee (SEC) of the...
AIDAN slams approval of Covaxin, expresses alarm over lack of efficacy, trial data Farhat Nasim5 Jan 2021 4:42 PM ISTNew Delhi: Slamming the recent approval of Covid-19 vaccine, Covaxin, developed by Bharat Biotech in association with the Indian Council of...
CDSCO panel directs Themis Medicare to conduct blinded trial of Inosine Pranobex in Moderate Covid-19 patient MD Bureau3 Jan 2021 11:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation (CDSCO) recently recommended Themis...
NPPA to issue show-cause notice to Intas, Mankind Pharma for selling diabetes drug sans approval MD Bureau2 Jan 2021 4:56 PM ISTNew Delhi: Coming down on Mankind Pharma and Intas Pharmaceuticals, the National Pharmaceutical Pricing Authority (NPPA) has decided to issue...
